ASNS and liver cancer: Consistent with our recent findings in pediatric liver cancer [26], we also observed that CM272 markedly reduced the expression of amino acid metabolic enzymes (ASNS, PYCR1, BCAT2), as well as genes involved in the serine pathway (PHGDH, PSPH, PSAT1).